Rock Springs Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History
Bought
Maintained
Sold
Rock Springs Capital Management's TBIO Position: Q3 2021 in Review
Rock Springs Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 693,266 shares — an estimated $19.1M sold.
Rock Springs Capital Management first reported a position in TBIO in Q2 2018 and held it in 13 quarters. The position peaked at $19.1M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.
- Rock Springs Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- Rock Springs Capital Management sold 693,266 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $19.1M.
- Rock Springs Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 13 quarters.
- Rock Springs Capital Management's Translate Bio, Inc. Common Stock position peaked at $19.1M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.
Based on Rock Springs Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.